Connection

Miriam Lichtner to Off-Label Use

Back to Details
This is a "connection" page, showing publications Miriam Lichtner has written about Off-Label Use.
Miriam Lichtner
Connection Strength
0.038
Off-Label Use
  1. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. J Transl Med. 2020 10 21; 18(1):405.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.